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Comparative genomic analysis of a wild-type strain of the ovine pathogen Chlamydia abortus and its
nitrosoguanidine-induced, temperature-sensitive, virulence-attenuated live vaccine derivative identified 22
single nucleotide polymorphisms unique to the mutant, including nine nonsynonymous mutations, one leading
to a truncation of pmpG, which encodes a polymorphic membrane protein, and two intergenic mutations
potentially affecting promoter sequences. Other nonsynonymous mutations mapped to a pmpG pseudogene and
to predicted coding sequences encoding a putative lipoprotein, a sigma-54-dependent response regulator, a
PhoH-like protein, a putative export protein, two tRNA synthetases, and a putative serine hydroxymethyl-
transferase. One of the intergenic mutations putatively affects transcription of two divergent genes encoding
pyruvate kinase and a putative SOS response nuclease, respectively. These observations suggest that the
temperature-sensitive phenotype and associated virulence attenuation of the vaccine strain result from dis-
rupted metabolic activity due to altered pyruvate kinase expression and/or alteration in the function of one or
more membrane proteins, most notably PmpG and a putative lipoprotein.
The Chlamydiaceae represent a group of obligate intracel-
lular bacteria responsible for a wide range of diseases in many
different hosts with significant and broad economic and public
health impacts. Despite the global impact of chlamydial disease,
vaccines are available for only two chlamydial species, Chlamydia
abortus and Chlamydia felis, which infect ovine and feline species,
respectively. A formalin-inactivated vaccine against C. abortus
infection, which in the United Kingdom costs the agricultural
industry an estimated £20 million each year (2), was developed in
the 1960s but did not offer complete protection and required
revaccination every 3 years. This vaccine subsequently became
demonstrably ineffective when C. abortus infections occurred in
vaccinated flocks in the late 1970s (1, 14). Although inactivated
vaccines are still used, more effective C. felis and C. abortus vac-
cines derived from live attenuated strains are also available. How-
ever, C. felis reinfection is not completely controlled with the live
attenuated C. felis vaccine, as vaccinated animals still shed chla-
mydiae (32). In contrast, the live attenuated C. abortus vaccine
blocks reinfection and shedding (24, 25).
The C. abortus vaccine is based on a live attenuated strain
obtained by nitrosoguanidine (NTG) mutagenesis of the virulent
strain AB7, isolated from an aborted lamb (8). NTG causes
mutations by methylation of nucleotides, especially of gua-
nine, which can then pair with thymine or cytosine (16),
giving rise to a GC-to-AT conversion. Other nucleotide sub-
stitutions are seen less frequently with deletions resulting
from lesion repair. Treatment of AB7 with NTG produced
two temperature-sensitive mutants, 1B and 1H, which were
attenuated in the mouse model (21). Unlike 1H, which was
unstable in temperature-sensitive growth studies, the 1B
mutant was stable after multiple passages in vitro or in vivo
(23). The 1B mutant is characterized by a reduced ability to
induce death in utero of baby mice or lambs (21, 24) and was
able to protect against C. abortus infection in goats and
sheep (6, 22, 24–26). Additionally, this vaccine elicited pro-
tective immunity when administered in conjunction with live
Brucella and Salmonella vaccines or with a Toxoplasma live
vaccine (6, 19, 28). Although the 1B mutant strain is cur-
rently used commercially in the United Kingdom and other
parts of the world for vaccination of sheep and goats, the
genetic basis of the attenuation remains unknown, owing to
the random nature of NTG mutagenesis.
Comparative genome resequencing (CGR) methodolo-
gies allow comparative genomic analysis of closely related
genomes by using two microarray-based steps, a mapping
phase and a resequencing phase, with approximately 95% of
single nucleotide polymorphisms (SNPs) correctly identi-
fied. In this study, CGR was used to identify differences
between the reference strain S26/3 (30) and the wild-type
strain AB7 and to identify the mutations specific to the
NTG-generated mutants 1B and 1H. In addition to poten-
tially identifying pathogenic mechanisms, this approach en-
ables the “tolerance” for genomic variation between two
virulent isolates of C. abortus to be examined. Finally, as the
first whole-genome analysis of an NTG-induced mutant mi-
croorganism, our study provides a model for the distribution
and specificity of NTG mutagenesis in bacteria.
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Bacterial strains. The reference strain, C. abortus S26/3, was isolated from a
vaccinated ewe in 1979 (30). C. abortus AB7 is a wild-type strain isolated from an
aborted lamb (8), while C. abortus 1B and 1H are NTG-derived mutants of the
wild-type AB7 strain (21, 24). C. abortus strains were cultured essentially as
previously described in McCoy cells in minimal essential medium with 10% fetal
bovine serum (21). Three additional low-passage-number wild-type isolates,
EBA-Colorado (Cola), isolated from placenta from a bovine abortion; EBA-LX-
578-12 (LX), isolated from an aborted bovine fetus; and LW-508 (LW508),
isolated from a calf with enteritis, were obtained from Bernhard Kaltenboeck
(Auburn University) and cultured in Iscove’s modified Dulbecco medium with 2
g/l amphotericin B (Fungizone), 25 g/l gentamicin, and 10% fetal bovine
serum, as previously described (13).
DNA isolation. Chlamydiae were purified from culture lysates as previously
described (4). DNA was extracted from purified chlamydiae by using phenol-
chloroform-isoamyl alcohol extraction as previously described (3). DNA concen-
tration and quality were determined by optical density at 260 nm/optical density
at 280 nm and agarose gel electrophoresis.
Resequencing and analysis. DNA isolated from the four strains was processed
for mapping and resequencing by Nimblegen, Inc. Mapping arrays were designed
based on the genome sequence of the C. abortus S26/3 strain (30), referred to
here as the reference strain, with 28-bp probes staggered every 8 bp along the
genome, and hybridized to DNA of the three test strains, AB7, 1B, and 1H.
Following mapping analysis, a second set of microarrays was designed for rese-
quencing. These arrays had probes designed for each possible SNP within a
region of interest, as defined by a significant signal ratio identified upon analysis
of the mapping data. The resequencing arrays were run twice for each of the test
strains. The mapping and resequencing data were analyzed to identify SNPs and
regions of interest without called SNPs, by using SignalMap (Nimblegen, Inc.)
and Microsoft Office Excel.
PCR sequencing. Probes were designed to regions approximately 350 bp up-
stream and downstream of a called SNP or other sites of interest by using
DNAStar PrimerSelect (see Table S1 in the supplemental material). The ampli-
con was then generated by PCR using Taq HiFi polymerase (Invitrogen), ac-
cording to the manufacturer’s protocol. The amplicon sequence was aligned
against the reference genome sequence using BLAST and DNAStar’s Megalign.
Analysis of mutations. Nonsynonymous SNPs were further analyzed, using a
BLOSUM80 matrix, to determine if the amino acid substitution resulted in a
conservative or a nonconservative change.
RESULTS
Mapping analysis. Three test strains (AB7, 1B, and 1H)
were compared to the S26/3 reference strain to determine the
feasibility of resequencing and to gain a preliminary assess-
ment of strain relatedness (data not shown). This analysis
confirmed that the two mutants were derived from AB7, as all
regions of AB7 with significant signal ratios relative to that of
S26/3 were also found in 1B and 1H. In addition, all regions of
1H with significant signal ratios were also identified in 1B,
suggesting that 1B was derived from 1H. Results of the map-
ping analysis showed that the strains were sufficiently closely
related for resequencing.
Verification of resequencing results. A total of 677 potential
SNPs present in at least one strain were identified by the
resequencing arrays. For each strain, results of two resequenc-
ing microarrays were compared for reproducibility. Any puta-
tive SNP found only once in all six microarrays (n  55) was
deemed a false positive. Selected SNPs among these and
corresponding apparent missed calls were amplified and se-
quenced for confirmation. The remaining 622 SNPs were
categorized according to the probability of representing a
true mutation and based on the perceived level of importance
of the corresponding mutation. With respect to SNP call ac-
curacy, three categories included SNPs called consistently in all
genomes, SNPs called in only one or two genomes, and SNPs
near other SNPs. Among these, SNPs generating putative vir-
ulence-associated mutations and mutant-associated SNPs lead-
ing to intergenic or nonsynonymous mutations received par-
ticular attention. SNPs called in only one or two genomes were
often characterized by a significantly altered signal ratio in the
second and/or third genome and were presumed to result from
an apparent missed SNP call at the same location in the
other genome(s). Several of these SNPs were amplified and
sequenced to verify their presence in all genomes. A second
questionable SNP category was composed of SNPs occurring
within 20 bp of each other, likely representing errors arising
from the overlapping microarray probes. The majority of these
neighboring SNP segments were sequenced, and most were
confirmed with one valid SNP. All SNPs that had the potential
to encode specific alterations in proteins of 1H or 1B were
confirmed by PCR sequencing. Additionally, several SNPs
mapping to intergenic regions or resulting in silent mutations
in the mutants were confirmed by sequencing. However, most
SNPs identified in the mutants (n  24) were also present in
AB7, while another four were found to be false positives.
Finally, a set of regions with significantly altered ratios that
lacked any associated SNPs were sequenced based on the pre-
sumption that these might contain nucleotide insertions and
deletions that the resequencing microarrays could not resolve.
Comparative genomics of two virulent C. abortus isolates,
AB7 and S26/3. A total of 591 SNPs affecting 363 different
predicted annotated genes or coding sequences (CDSs) and 66
predicted intergenic regions were identified in AB7 relative to
S26/3 (see Table S2 in the supplemental material). Seven de-
letions and 11 insertions ranging from single nucleotide inser-
tions (n  5) or deletions (n  3) to larger mutations of up to
23 deleted nucleotides and 57 inserted nucleotides were also
identified. Mutations were distributed evenly throughout the
AB7 genome with no discernible hot spots (Fig. 1). In total,
318 mutations in 255 known or predicted protein-coding CDSs,
including 22 pseudogenes, were identified (see Table S3 in the
supplemental material).
Consistent with their earlier characterization as a highly
polymorphic gene family (9, 29), 3 of the 14 genes with more
than two protein-altering mutations are pmp genes, one being
a predicted pmpG pseudogene. A total of 254 genes/CDSs had
at least one mutation leading to an alteration in the predicted
protein sequence; however, 16 of these are pseudogenes, sug-
gesting that these SNPs are unlikely to effect a functional
change. Most of the remaining CDSs encode hypothetical pro-
teins (n  64) or proteins with an unknown function (n  20)
(Fig. 2).
The second largest group of SNP-bearing CDSs (n  31)
encode predicted cell envelope proteins (Fig. 2). Consistent
with their “housekeeping” roles, genes encoding predicted
functions in regulation, protein synthesis, central intermediary
metabolism, transcription, fatty acid and lipid metabolism,
and synthesis of nucleotides, cofactors, carriers, and pros-
thetic groups were altered less frequently than were those
associated with putative roles in pathogenesis or subjected
to innate or adaptive immune pressures (Fig. 2).
Only 10 genes (CAB041, CAB416, CAB502, CAB541,
CAB547, CAB557, CAB564, CAB786, CAB852, and CAB853)
were found to have intragenic deletions or insertions in AB7
compared to S26/3. CAB541 is a pseudogene conserved in
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both strains. Of the remaining nine, only CAB786, encoding
a 30S ribosomal protein with an internal deletion of 5 amino
acids (aa) in AB7, has a known function. The remainder
consist of hypothetical proteins including a putative export
protein (CAB502, with a 49-aa truncation in AB7) and a
conserved membrane protein (CAB852 fused with the hy-
pothetical protein CAB853 in AB7). Orthologs of the
CAB852/CAB853 fusion have been previously described within
the rrn-nqrF intergenic segment of C. abortus (15).
Analysis of the NTG-induced SNPs in the mutants. Neither
deletions nor insertions were identified in either 1B or 1H
compared to AB7, consistent with previous observations of
nucleotide conversions predominantly occurring as the result
of NTG mutagenesis (16). Most (73%) of the SNPs were GC-
to-AT conversions, confirming the known mutagenic bias of
NTG. A total of 22 randomly distributed mutant-specific SNPs
were identified (Fig. 1; Table 1). All but two SNPs were found
in both mutants, suggesting that 1B, possessing the additional
two unique SNPs, is derived from 1H. Ten of these mutations,
including those unique to 1B, induced synonymous coding
changes, while three were located in intergenic regions poten-
tially affecting promoters of CAB186, CAB645, and CAB646.
The remaining nine nonsynonymous mutations (Table 2) have
the potential to affect the function of the encoded protein(s)
and as such may contribute to strain attenuation individually or
cumulatively.
(i) PmpG mutations. Mutations were identified in two
different pmpG alleles, CAB283 and CAB273. The replace-
ment of a single stop codon with a leucine residue in
CAB273 is likely not significant, as CAB273 is a pseudogene
with numerous other truncating stop codons. A mutation in
the complete, uninterrupted CAB283 pmpG allele, however,
introduces a stop at W866X, resulting in the loss of 512 aa,
or 37% of the predicted PmpG protein. The truncated seg-
ment encompasses most of the predicted autotransporter
barrel domain, which would prevent proper insertion of the
protein in the outer membrane.
(ii) CAB153/putative sigma-54-dependent response regula-
tor. The E4K substitution found in CAB153, encoding a puta-
tive sigma-54-dependent response regulator, is unlikely to
cause any significant functional alteration, as the same substi-
tution is observed in Chlamydia pneumoniae (10, 20, 27), sug-
gesting that this region of the protein is unessential for func-
tion or that the protein’s activity can tolerate the mutation.
FIG. 1. Genome comparison of S26/3, AB7, 1B, and 1H. Mutations in AB7 and the two mutant strains, relative to the S26/3 reference genome
backbone, are indicated. From the outermost circle inward: circles 1 and 2, CDSs on the plus and minus strands, respectively, color coded as
previously described (17) according to role category classification, as determined for the reference S26/3 genome; circle 3, SNPs present in AB7
relative to S26/3; circle 4, SNPs in both 1H and 1B (black) and those unique to 1B (red); circle 5, GC skew of the S26/3 genome; circle 6, GC
content of the S26/3 backbone.
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(iii) CAB175/putative export protein. The V722I substitution
in CAB175 is similarly unlikely to alter function, as the same
substitution is found in orthologs of C. pneumoniae, Chlamydia
muridarum, and C. felis (not shown). Additionally, alignment with
the sequence of the SecD domain in which the mutation occurs
reveals similar sequence variation at the same position.
(iv) CAB308/putative lipoprotein. The E350K substitution in
CAB308 does not reside within a characterized domain of the
FIG. 2. Role category distribution for genes altered in AB7 relative to S26/3.
TABLE 1. Mutations unique to 1H and 1B
Genomic
positiona SNP











110655 C to A   Syn R R CAB096 NAh NA
147575 C to T   Syn I I CAB139 NA NA
164301 C to T   Yes Non E K CAB153 NA NA
189518 G to A   Yes Non V I CAB175 NA NA
205074 C to T   Intg NA NA NA CAB185/CAB186 160/38
241667 G to A   Yes Non D N CAB220 NA NA
247417 G to A   Syn P P CAB227 NA NA
312724 C to A   Non *i L CAB273 NA NA
323028 G to A   Yes Syn L L CAB281 NA NA
328034 C to T   Yes Non W * CAB283 NA NA
335181 T to C   Intg NA NA NA CAB287/CAB288 21/102
358346 C to T   Yes Non E K CAB308 NA NA
429384 T to C   Syn V V CAB373 NA NA
453290 A to C   Syn L L CAB394 NA NA
542479 A to G   Yes Syn L L CAB469 NA NA
716144 C to T   Yes Non E K CAB622 NA NA
731338 C to T   Yes Non G D CAB636 NA NA
744408 C to T   Intg NA NA NA CAB645/CAB646 146/147
754284 G to A   Yes Non P S CAB648 NA NA
891683 A to T   Syn S S CAB772 NA NA
974264 G to A   Syn L L CAB842 NA NA
1036695 A to C   Syn A A CAB887 NA NA
a Position of an SNP, the preceding nucleotide of an insertion, or the first nucleotide of a deletion on the S26/3 genome.
b Observed nucleotide conversion.
c Result for verification of SNPs by PCR sequencing.
d Effect of mutation on protein sequence or location outside a CDS: nonsynonymous (Non) or synonymous (Syn) codon change or intergenic location (Intg).
e CDS designation.
f Genes upstream and downstream of an intergenic mutation.
g Nucleotide distance of the SNP from the upstream and downstream genes.
h NA, not applicable.
i *, stop codon.
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predicted lipoprotein. BLAST analysis shows that all Chlamy-
diaceae orthologs maintain the glutamate residue and that
flanking sequences are highly conserved, suggesting the possi-
bility that the resulting 2 charge modification of the mutant
protein may affect an uncharacterized domain that is impor-
tant for function.
(v) CAB220/putative serine hydroxymethyltransferase. The
D248N mutation in CAB220 occurs within the serine hydroxym-
ethyltransferase domain (PFAM00464) of the predicted gene
product. Comparative analysis of 250 orthologs by BLAST-P
reveals a single ortholog (43% identity) in Anaeromyxobacter
dehalogenans containing an asparagine at that site. Only 50
orthologs had a residue other than glutamate or aspartate, and
of these, 42 were lysine, 3 were arginine, and 2 were histidine
residues (data not shown), suggesting that selective pressure
exists to maintain a charged residue at this position.
(vi) CAB622/methionyl-tRNA synthetase. BLAST-P analysis
indicates that the E70K mutation in CAB622 occurs within a
conserved domain of the predicted protein. However, while
nearly 75% of the orthologs maintained either a glutamate or
an aspartate at that position, two were found with a lysine
residue at the same site as the mutated residue in CAB622 (not
shown).
(vii) CAB648/valyl-tRNA synthetase. The nonconservative
P444S substitution in CAB648 encoding a predicted valyl-
tRNA synthetase does not occur within either of the two
motifs associated with ATP binding by the enzyme. Align-
ment with the consensus sequence of the ValRS catalytic
core domain (cd00817) places a serine residue at the position
corresponding to the mutant serine residue. Furthermore, an
alignment of known valyl-tRNA synthetases shows relatively re-
duced sequence conservation in this segment compared to that in
other segments of the domain.
(viii) CAB636/PhoH-like protein. The nonconservative
G410D substitution in CAB636 may be significant, as all of the
closest orthologs have a glycine, serine, alanine, or valine res-
idue at the same position (data not shown). CAB636 encodes
a putative phosphate starvation-inducible protein, based on its
sequence similarity to Escherichia coli PhoH, which has been
shown to be induced under phosphate-limiting conditions and
to bind ATP (11). Members of the Pho regulon, including
PhoH, are upregulated under phosphate-limiting conditions by
PhoB. BLAST analysis of C. abortus identified two E. coli
PhoB orthologs, CAB153 (30% identity), the putative sigma-
54-dependent response regulator which is also altered in the
mutants (see above), and CAB977 (31% identity).
DISCUSSION
Comparison of wild-type strains AB7 and S26/3 allowed
investigation of C. abortus genomic variation. With the excep-
tion of CAB789, encoding a 30S ribosomal protein, no gene
with a known function displays an SNP affecting more than one
amino acid change between the two wild-type strains. Addi-
tionally, all pseudogenes are conserved in the two isolates.
However, the number of mutations in proteins with unknown
function is significant and could lead to important functional
differences between these strains. Overall, alterations identi-
fied in AB7 relative to S26/3 are consistent with general in-
traspecies variation.
Comparative analysis of the parent and mutant strains pro-
vided genome-level verification of the NTG-induced GC-to-AT
conversion bias and of NTG causing SNPs rather than deletions
and/or insertions. Although the number of mutations induced
by NTG mutagenesis was low (22 SNPs), there was no appar-
ent bias in the numbers of synonymous SNPs, intergenic SNPs,
and nonsynonymous SNPs (10, 3, and 9, respectively), which
suggests that the small C. abortus genome tolerates mutations.
While the CGR method used here does identify most SNPs
(95%) as well as insertions and deletions, some mutations
may be missed. Hence, we cannot rule out the possibility of a
missed SNP in 1H leading to the observed instability of this
attenuated mutant. However, it is less likely that the muta-
tion(s) responsible for the virulence-attenuated phenotype of
both mutants could have been missed, since such mutations
would have to have been missed simultaneously in 1H and 1B.
Another possible reason for the observed differential proper-
ties of the two mutants (21, 24) is that the two “silent” muta-
tions identified as unique to 1B affect a regulatory sequence or
alter protein folding. Kimchi-Sarfaty et al. have recently re-
ported that alteration of a codon to a rare codon can delay
translation, leading to alterations in protein folding (12).
Analysis of C. abortus codon usage via the Codon Usage
Database (http://www.kazusa.or.jp/codon/) shows that the
conversion from CTT (21.54/1,000) to the less common CTC
codon (12.07/1,000) in CAB469 of 1B could represent such a
case. Notwithstanding this possibility, the mutations identified
in CDSs and annotated genes offer some intriguing insights
into the possible basis or bases for the attenuated virulence
phenotype and conversely into C. abortus pathogenesis. More-
over, genomic sequence information specific to 1B will provide
powerful diagnostic tools for identifying wild-type C. abortus-
infected animals in C. abortus 1B-vaccinated flocks. Because of
the uncertainty surrounding genotypic and phenotypic features
of 1H, the following discussion is principally focused on the 1B
mutant, i.e., the virulence-attenuated strain currently used as a
live vaccine.
NTG-induced virulence-attenuating mutations of 1B do not


















CAB273 Polymorphic outer membrane
protein (pseudogene)
312724 *e L
CAB283 Polymorphic outer membrane
protein
328034 W *
CAB308 Putative lipoprotein 358346 E K




CAB648 Valyl-tRNA synthetase 754284 P S
a Common/annotated denomination.
b SNP position on the reference genome.
c Original amino acid residue resulting from the SNP.
d Mutant amino acid residue resulting from the SNP.
e *, stop codon.
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cause loss of a central function, as the mutant replicates nor-
mally in McCoy cells, producing plaques of the same size and
morphology as those of AB7 plaques when grown at 35 to 38°C
(21). It is only when strains are grown at 39.5°C that any growth
difference is observed, suggesting that a genotypic alteration(s)
of the mutant becomes critical only at the higher temperature
of the ovine host. Three protein mutations appear most likely
to lead to the observed phenotype: the W-to-X translational
stop mutation of CAB283, producing a truncated, secretion-
incompetent PmpG protein; the E-to-K mutation in CAB308,
potentially encoding an altered membrane-destabilizing lipopro-
tein; and the combined E-to-K and G-to-D mutations, potentially
altering the functions of CAB153 and CAB636, two key proteins
of the Pho regulon in other bacteria.
Members of the pmp family encode a group of predicted
autotransported proteins that may be important in pathogen-
esis, including the ability to evade host immune responses by
antigenic variation (5, 7, 18, 29, 31). The observation that 1B
grows normally in vitro suggests that the loss of PmpG does not
affect invasion, replication, or lysis of the host cell. Indeed, the
mutant phenotype supports a role for PmpG specific to sur-
vival at elevated temperatures or when the bacterium is sub-
jected to immune pressure during infection of live animals.
Although the possibility exists for other pmpG genes to com-
plement the CAB283 mutation, our results support the idea
that the absence of the CAB283 PmpG protein at the surface
of C. abortus contributes to the observed virulence attenuation.
The CAB308-encoded putative lipoprotein is found in all
members of the Chlamydiaceae and displays less than 30%
identity to CDSs in other bacteria, suggesting that this protein
is Chlamydia specific and as such may be critical for chlamydial
biology. Sequence alignment of the putative lipoprotein within
the Chlamydiaceae reveals that the region encompassing the
mutation is well conserved, suggesting that it may be critical for
function. It is therefore possible that the E-to-K charge shift in
CAB308 could hinder the ability of this protein to interact with
a putative ligand and that the effects of such a mutation would
be more pronounced at higher temperatures.
The final protein mutations of interest encompass two po-
tentially related CDSs, CAB636 and CAB153, respectively en-
coding orthologs of PhoH and PhoB of E. coli. The activator
PhoB protein upregulates genes of the Pho regulon during
phosphate starvation. Although the similarity of CAB153 and
PhoB is limited, it is tempting to speculate that the observed
E-to-K mutation in CAB153 could affect regulation of chla-
mydial pho promoters, including that of the phoH ortholog,
CAB636. Functional disruption owing to the G-to-D mutation
in mutant CAB636 could be further exacerbated by disrupted
transcription mediated by the PhoB-like CAB153. However, as
no function has been identified for PhoH in E. coli, the impact
of the Pho protein mutations on chlamydial biology remains
entirely speculative.
An intriguing possible explanation for the virulence attenu-
ation observed in 1B results from an SNP in the intergenic
space predicted to include the promoter of CAB645 encoding
the predicted single-copy chlamydial pyruvate kinase. In pre-
liminary experiments, CAB645 transcript was detected at both
37°C and 39.5°C in the parent AB7 strain but only at 37°C in
the 1B mutant. Although transcript amounts were small in these
experiments (data not shown), this result, if confirmed, would
suggest that expression of this essential central metabolism gene
is downregulated in the mutant at the animal’s body temperature
of 39.5°C, with downstream negative consequences for replication
and transcriptional activity during infection. It is also an intriguing
possibility that the same intergenic SNP could affect transcription
of the divergently transcribed CAB646 at 39.5°C. Reduced ex-
pression of the putative SOS response nuclease encoded by
CAB646 could lead to reduced survival during stressed condi-
tions, such as elevated temperatures.
This study has yielded some intriguing insights into chla-
mydial pathogenesis and revealed that the attenuation ob-
served in the virulence-attenuated C. abortus mutant is not
the result of a single critical mutation but rather the cumu-
lative and complex effect of several. The proposed reduced
transcription of the predicted pyruvate kinase gene and the
implied impact on central metabolism support a role for this
mutation as a direct cause of virulence attenuation. Mutations
affecting surface proteins may then contribute to the virulence-
attenuated phenotype by simultaneously diminishing the
pathogenic potential and enhancing the immunogenic proper-
ties of live vaccine C. abortus.
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